PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations

被引:71
作者
di Blasio, Laura [1 ,2 ]
Puliafito, Alberto [1 ]
Gagliardi, Paolo Armando [1 ]
Comunanza, Valentina [1 ,2 ]
Somale, Desiana [1 ,2 ]
Chiaverina, Giulia [1 ,2 ]
Bussolino, Federico [1 ,2 ]
Primo, Luca [1 ,2 ]
机构
[1] Candiolo Canc Inst FPO IRCCS, I-10060 Turin, Italy
[2] Univ Turin, Dept Oncol, I-10100 Turin, Italy
来源
CELL DEATH & DISEASE | 2018年 / 9卷
关键词
LYMPHATIC ENDOTHELIAL-CELLS; SOMATIC MUTATIONS; ACTIVATING MUTATIONS; SECRETORY PHENOTYPE; PIK3CA CAUSE; SENESCENCE; PI3K; ANGIOGENESIS; MIGRATION; MTOR;
D O I
10.1038/s41419-017-0064-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Somatic activating mutations within the PIK3CA gene have been recently detected in sporadic lymphatic and venous malformations, and in vascular malformations (VM) associated to overgrowth syndromes, such as CLOVES and Klippel-Trenaunay syndrome. Although VM are often limited to specific tissue areas and can be well treated, in extended or recurrent lesions novel therapeutic approaches are needed. We generated a mouse model of VM by local expression of PIK3CA-activating mutation in endothelial cells. PIK3CA-driven lesions are characterized by large areas of hemorrhage, hyperplastic vessels, infiltrates of inflammatory cells, and elevated endothelial cell density. Such vascular lesions are ameliorated by administration of dual PI3K/mTOR inhibitor, BEZ235, and mTOR inhibitor, Everolimus. Unexpectedly, the expression of PIK3CA-activating mutations in human endothelial cells results in both increased proliferation rates and senescence. Moreover, active forms of PIK3CA strongly promote the angiogenic sprouting. Treatment with PI3K/mTOR inhibitors restores normal endothelial cell proliferation rate and reduces the amount of senescent cells, whereas treatment with Akt inhibitor is less effective. Our findings reveal that PIK3CA mutations have a key role in the pathogenesis of VM and PIK3CA-driven experimental lesions can be effectively treated by PI3K/mTOR inhibitors.
引用
收藏
页数:15
相关论文
共 38 条
  • [1] Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
    Adams, Jessica R.
    Xu, Keli
    Liu, Jeff C.
    Agamez, Natalia M. Ruiz
    Loch, Amanda J.
    Wong, Ruth G.
    Wang, Wei
    Wright, Katherine L.
    Lane, Timothy F.
    Zacksenhaus, Eldad
    Egan, Sean E.
    [J]. CANCER RESEARCH, 2011, 71 (07) : 2706 - 2717
  • [2] AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy
    Astle, M. V.
    Hannan, K. M.
    Ng, P. Y.
    Lee, R. S.
    George, A. J.
    Hsu, A. K.
    Haupt, Y.
    Hannan, R. D.
    Pearson, R. B.
    [J]. ONCOGENE, 2012, 31 (15) : 1949 - 1962
  • [3] AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation
    Boscolo, Elisa
    Coma, Silvia
    Luks, Valerie L.
    Greene, Arin K.
    Klagsbrun, Michael
    Warman, Matthew L.
    Bischoff, Joyce
    [J]. ANGIOGENESIS, 2015, 18 (02) : 151 - 162
  • [4] HEPATOCYTE GROWTH-FACTOR IS A POTENT ANGIOGENIC FACTOR WHICH STIMULATES ENDOTHELIAL-CELL MOTILITY AND GROWTH
    BUSSOLINO, F
    DIRENZO, MF
    ZICHE, M
    BOCCHIETTO, E
    OLIVERO, M
    NALDINI, L
    GAUDINO, G
    TAMAGNONE, L
    COFFER, A
    COMOGLIO, PM
    [J]. JOURNAL OF CELL BIOLOGY, 1992, 119 (03) : 629 - 641
  • [5] Somatic PIK3CA mutations as a driver of sporadic venous malformations
    Castel, Pau
    Carmona, F. Javier
    Grego-Bessa, Joaquim
    Berger, Michael F.
    Viale, Agnes
    Anderson, Kathryn V.
    Bague, Silvia
    Scaltriti, Maurizio
    Antonescu, Cristina R.
    Baselga, Eulalia
    Baselga, Jose
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (332)
  • [6] Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans
    Castillo, Sandra D.
    Tzouanacou, Elena
    Zaw-Thin, May
    Berenjeno, Inma M.
    Parker, Victoria E. R.
    Chivite, Inigo
    Mila-Guasch, Maria
    Pearce, Wayne
    Solomon, Isabelle
    Angulo-Urarte, Ana
    Figueiredo, Ana M.
    Dewhurst, Robert E.
    Knox, Rachel G.
    Clark, Graeme R.
    Scudamore, Cheryl L.
    Badar, Adam
    Kalber, Tammy L.
    Foster, Julie
    Stuckey, Daniel J.
    David, Anna L.
    Phillips, Wayne A.
    Lythgoe, Mark F.
    Wilson, Valerie
    Semple, Robert K.
    Sebire, Neil J.
    Kinsler, Veronica A.
    Graupera, Mariona
    Vanhaesebroeck, Bart
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (332)
  • [7] PDK1 regulates focal adhesion disassembly by modulating endocytosis of αvβ3 integrin
    di Blasio, Laura
    Gagliardi, Paolo Armando
    Puliafito, Alberto
    Sessa, Roberto
    Seano, Giorgio
    Bussolino, Federico
    Primo, Luca
    [J]. JOURNAL OF CELL SCIENCE, 2015, 128 (05) : 863 - 877
  • [8] di Blasio L, 2015, METHODS MOL BIOL, V1214, P41, DOI 10.1007/978-1-4939-1462-3_4
  • [9] A BIOMARKER THAT IDENTIFIES SENESCENT HUMAN-CELLS IN CULTURE AND IN AGING SKIN IN-VIVO
    DIMRI, GP
    LEE, XH
    BASILE, G
    ACOSTA, M
    SCOTT, C
    ROSKELLEY, C
    MEDRANO, EE
    LINSKENS, M
    RUBELJ, I
    PEREIRASMITH, O
    PEACOCKE, M
    CAMPISI, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) : 9363 - 9367
  • [10] Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration
    Graupera, Mariona
    Guillermet-Guibert, Julie
    Foukas, Lazaros C.
    Phng, Li-Kun
    Cain, Robert J.
    Salpekar, Ashreena
    Pearce, Wayne
    Meek, Stephen
    Millan, Jaime
    Cutillas, Pedro R.
    Smith, Andrew J. H.
    Ridley, Anne J.
    Ruhrberg, Christiana
    Gerhardt, Holger
    Vanhaesebroeck, Bart
    [J]. NATURE, 2008, 453 (7195) : 662 - 666